z-logo
open-access-imgOpen Access
Predictors of eligibility for reimbursement of antiviral treatment in HBe-Ag negative chronic hepatitis B patients with high ALT levels
Author(s) -
İsmail Engin,
Ali Duman,
Hayriye Esra Ataoğlu,
Aslı Örmeci,
Şule Poturoğlu
Publication year - 2022
Publication title -
journal of surgery and medicine
Language(s) - English
Resource type - Journals
ISSN - 2602-2079
DOI - 10.28982/josam.1012592
Subject(s) - medicine , liver biopsy , gastroenterology , hbeag , reimbursement , hepatitis b virus , hepatitis b , hepatitis c , hepatology , biopsy , hbsag , immunology , virus , health care , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom